Data Foundry

Medical device recalls 2020

Atellica CH Total Bilirubin_2 assay-In vitro Diagnostic for the… — Class II medical device recall Z-1537-2020

Terminated recall by Siemens Healthcare Diagnostics, Inc., reported 2020-04-01, distributed nationwide. Bilirubin assays may exhibit a positive bias with patients on eltrombopag therapy

Recall numberZ-1537-2020
Product typeMedical device
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmSiemens Healthcare Diagnostics, Inc., Newark, DE, United States
Recall initiated2020-02-13
Classified2020-03-20
Reported by FDA2020-04-01
Terminated2021-04-23
DistributedNationwide (US)
Countries outside the USAE, AF, AR, AT, AU, BD, BE, BG, BH, BR, BS, CA, CH, CL, CN, CO, CY, CZ, DE, DK, DZ, EC, EE, EG, ES, FI, FR, GB, GR, HK, HR, HU, ID, IE, IL, IN, IQ, IR, IS, IT, JO, JP, KE, KR, KW, LB, LT, LV, MA, MT, MX, MY, NG, NL, NO, NZ, OM, PE, PH, PK, PL, PT, QA, RO, RS, SA, SE, SG, SI, SK, TH, TN, TR, TW, UA, UY, VE, VN, ZA
UPC / GTIN / UDI-DI00630414595818
Lot numbers190028, 190063, 190112, 190152, 190205, 190235, 190265

Product

Atellica CH Total Bilirubin_2 assay-In vitro Diagnostic for the determination of total bilirubin SMN: 11097531 - Product Usage: Atellica TBil_2 assay is for in vitro diagnostic use in the quantitative determination of total bilirubin in human serum and plasma (lithium heparin) of adults and neonates using the Atellica¿ CH Analyzer. Measurement of total bilirubin, an organic compound formed during the normal and abnormal destruction of red blood cells, is used in the diagnosis and treatment of liver, hemolytic, hematological, and metabolic disorders, including hepatitis and gallbladder block, A total bilirubin measurement in newborn infants is intended to aid in indicating the risk of bilirubin encephalopathy (kernicterus).

Reason for recall

Bilirubin assays may exhibit a positive bias with patients on eltrombopag therapy

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1537-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.